Kamfanin Cupertino shine mai matukar sha'awar lamuran kiwon lafiya. Idan muka kalli Apple Watch zamu fahimci cewa yawancin ayyukanta suna da alaƙa da wannan batun, kamar karanta ECG na Apple Watch Series 4, ƙararrawa na aiki, sabon aiki don kare kunnuwanmu daga yawan hayaniya mai ƙarfi, da sauransu, kuma da kadan kadan suke aiwatarwa da bincike don kara karin cigaba a wannan batun.
A wannan yanayin mun ga cewa labarai da suka shafi lamuran ciwon suga na ci gaba da faruwa a kamfanin Apple kuma kwanakin baya mun karanta labaran da Shugaba na kamfanin Dexcom, kevin Sayer, ya bayyana wa kafofin yada labarai cewa suna dab da samun sakamako daga aiki na tsawon shekaru tare da Apple don aiwatar da aikin da ya shafi karatun bayanan da suka shafi ciwon suga a kan agogo, a yau wani sabon labari game da wannan a shagunan kamfanin.
OneDrop shine ma'aunin glucose wanda Apple ya fara siyarwa a cikin shagunan sa
Wannan zai zama aikin da Apple yayi tare da wannan mitar da kuma tsarin auna sikarin glucose mara tasiri. OneDrop yana ba da wannan zaɓin kuma yanzu haɗuwa tare da "kayan aikin" da ake buƙata ana siyarwa a cikin shagunan Apple tare da farashin $ 69,65. Labaran da ke zuwa kai tsaye daga tsakiya CNBC, kuma a ciki zamu iya ganin yadda shekara ta horo har ila yau ta haɗa da hannun ƙwararren malamin ilimi don motsa jiki da rayuwa mai ƙoshin lafiya. Muna jiran Apple ya ci gaba da ƙara haɓakawa a wannan batun har zuwa lokacin da za a aiwatar da duk wannan a cikin agogon wayo na kamfanin, wanda tabbas anjima ko anjima yana gamawa yana zuwa.